Tpn Calculator
Calculate total parenteral nutrition formulation from patient weight, caloric, and protein needs.
Formula
Dextrose kcal = grams x 3.4; Protein kcal = grams x 4; Lipid 20% = 2 kcal/mL; GIR = (Dextrose g x 1000) / (Weight x 1440)
Dextrose monohydrate provides 3.4 kcal/g in IV solutions. Amino acids provide 4 kcal/g. Lipid emulsions provide 1.1 (10%), 2.0 (20%), or 3.0 (30%) kcal/mL. The glucose infusion rate (GIR) in mg/kg/min should stay below 4-5 to prevent metabolic complications. Osmolarity determines central vs peripheral access requirements.
Worked Examples
Example 1: Standard TPN Formulation
Problem: A 70 kg patient needs 2,000 kcal/day with 1.6 g/kg protein. Use D25, 10% amino acids, 20% lipid (30% of non-protein calories from lipid).
Solution: Protein: 70 x 1.6 = 112 g (448 kcal)\nNon-protein calories: 2,000 - 448 = 1,552 kcal\nLipid calories (30%): 1,552 x 0.30 = 466 kcal\nLipid volume: 466 / 2.0 kcal/mL = 233 mL of 20%\nDextrose calories: 1,552 - 466 = 1,086 kcal\nDextrose grams: 1,086 / 3.4 = 319 g\nDextrose volume: 319 / 0.25 = 1,278 mL of D25\nAmino acid volume: 112 / 0.10 = 1,120 mL of 10%
Result: D25: 1,278 mL | 10% AA: 1,120 mL | 20% lipid: 233 mL | GIR: 3.2 mg/kg/min
Example 2: Peripheral Parenteral Nutrition
Problem: A 65 kg patient needs short-term PPN (osmolarity <900 mOsm/L). Target 1,200 kcal with 75 g protein. Use D10 and 10% amino acids.
Solution: Protein: 75 g (300 kcal)\nNon-protein: 1,200 - 300 = 900 kcal\nLipid (40%): 360 kcal = 180 mL of 20% lipid\nDextrose: 540 kcal = 159 g D10\nDextrose volume: 159 / 0.10 = 1,590 mL\nAA volume: 75 / 0.10 = 750 mL\nOsmolarity estimate: (159x5 + 75x10)/(2.34) = 660 mOsm/L\nSuitable for peripheral line
Result: D10: 1,590 mL | 10% AA: 750 mL | 20% lipid: 180 mL | Osm: ~660 mOsm/L (peripheral OK)
Frequently Asked Questions
What is total parenteral nutrition (TPN) and when is it indicated?
Total parenteral nutrition is an intravenous feeding method that delivers all required macronutrients (dextrose, amino acids, and lipid emulsions), electrolytes, vitamins, trace elements, and water directly into the bloodstream, bypassing the gastrointestinal tract entirely. TPN is indicated when patients cannot receive adequate enteral nutrition due to intestinal failure, bowel obstruction, severe pancreatitis, high-output gastrointestinal fistulas, short bowel syndrome, severe mucositis from chemotherapy, or prolonged ileus. According to ASPEN guidelines, TPN should be considered when enteral nutrition fails to meet at least 60 percent of caloric goals after 7 to 10 days in previously well-nourished patients, or within 3 to 5 days in malnourished patients. Peripheral parenteral nutrition can be used for short-term supplementation.
How are dextrose calories calculated in TPN formulations?
Dextrose (D-glucose monohydrate) provides 3.4 kilocalories per gram in parenteral solutions, which is slightly lower than the 4 kcal/g for oral glucose because the monohydrate form contains water weight. Standard TPN dextrose concentrations range from 10 to 70 percent, with 25 percent (D25) and 50 percent (D50) being most common for central line administration. The total grams of dextrose needed is calculated by dividing the desired dextrose calories by 3.4 kcal/g. The volume of dextrose solution required equals grams needed divided by the concentration. For example, to provide 1,000 kcal from dextrose: 1,000 / 3.4 = 294 grams, requiring 1,176 mL of D25 solution. The glucose infusion rate (GIR) should not exceed 4 to 5 mg/kg/min in adults to prevent hyperglycemia and hepatic steatosis.
What is the significance of osmolarity in TPN formulations?
The osmolarity of a TPN solution determines whether it can be safely infused through a peripheral or central venous catheter. Solutions with osmolarity exceeding 900 mOsm/L must be administered through a central venous catheter because peripheral veins cannot tolerate hyperosmolar solutions without developing thrombophlebitis and potential vessel damage. Peripheral parenteral nutrition is generally limited to solutions below 900 mOsm/L, which typically restricts dextrose concentration to 10 to 12.5 percent. The osmolarity of TPN is primarily determined by the dextrose and amino acid concentrations, with each gram of dextrose contributing approximately 5 mOsm and each gram of amino acids contributing approximately 10 mOsm. Electrolytes also contribute to osmolarity. Standard central TPN with D25 and standard amino acids typically has osmolarity of 1,800 to 2,400 mOsm/L.
How should blood glucose be monitored and managed during TPN?
Hyperglycemia is the most common metabolic complication of TPN, occurring in up to 50 percent of critically ill patients receiving parenteral nutrition. Blood glucose should be monitored every 4 to 6 hours when initiating TPN and at least twice daily once stable. The target glucose range for ICU patients on TPN is generally 140 to 180 mg/dL, avoiding both hyperglycemia and hypoglycemia. Insulin can be added directly to the TPN bag (typically starting at 0.1 units per gram of dextrose) or administered as a separate continuous infusion for tighter control. The dextrose infusion rate should be advanced gradually over 24 to 48 hours to allow endogenous insulin production to adapt. When discontinuing TPN, the rate should be tapered over several hours rather than stopped abruptly to prevent rebound hypoglycemia from circulating insulin levels.
What electrolytes and micronutrients are included in TPN?
A complete TPN formulation includes multiple electrolytes, vitamins, and trace elements to prevent deficiency syndromes during exclusive parenteral feeding. Standard daily electrolyte requirements include sodium 1 to 2 mEq/kg, potassium 1 to 2 mEq/kg, chloride and acetate as needed for acid-base balance, calcium 10 to 15 mEq, magnesium 8 to 20 mEq, and phosphorus 20 to 40 mmol. A standard multivitamin preparation is added containing all fat-soluble (A, D, E, K) and water-soluble vitamins. Trace elements including zinc, copper, manganese, chromium, and selenium are added as a combined preparation. Iron is generally not added to TPN due to compatibility issues and infection risk but can be given separately. Electrolytes should be monitored daily initially and adjusted based on serum levels, with particular attention to potassium, phosphorus, and magnesium.
How is TPN-associated liver disease managed?
TPN-associated liver disease, also known as intestinal failure-associated liver disease, is a significant complication of long-term parenteral nutrition that ranges from mild steatosis to cholestasis and potentially irreversible cirrhosis. Multiple factors contribute including excessive dextrose calories causing hepatic lipogenesis, soybean-based lipid emulsions with inflammatory omega-6 fatty acids, lack of enteral stimulation leading to bile stasis, and micronutrient deficiencies. Management strategies include cycling TPN over 10 to 12 hours rather than continuous 24-hour infusion to allow hepatic rest, reducing dextrose calories and optimizing the lipid-to-carbohydrate ratio, switching to fish oil-based lipid emulsions which contain anti-inflammatory omega-3 fatty acids, providing even minimal enteral nutrition to maintain gut integrity and bile flow, and addressing bacterial overgrowth. Monitoring liver function tests weekly during long-term TPN is recommended.